STEPHANIE ESCHETE: Open Payments
NPI 1275980906 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 20 payments from 6 companies in 2025. Trend: 2023 $1,168 · 2024 $815 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $367 |
| Janssen Scientific Affairs, LLC | 4 | $190 |
| Gilead Sciences, Inc. | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 1 | $125 |
| GENZYME CORPORATION | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: LINZESS, RINVOQ, Livdelzi, IQIRVO, DUPIXENT, SKYRIZI, TREMFYA.
Industry payments across LA — which companies pay providers there.
